Pulmonary Rehabilitation in Interstitial Lung Diseases

Catholic University (KU) of Leuven

Status and phase: Completed; Phase 4

Conditions: Interstitial Lung Disease

Treatments: Other: Pulmonary Rehabilitation

Study type: Interventional

Funder types: Other

Identifiers

NCT00882817

B32220095560

S1490

Details and patient eligibility

About

Treatment in interstitial lung diseases (ILD) is frequently ineffective. Pulmonary rehabilitation (PR) is an excellent therapeutic option in another chronic lung diseases such as chronic obstructive pulmonary disease (COPD). This prospective randomized controlled study aims to evaluate the short and long-term effects of PR in patients with ILD. For this purpose, 60 ILD patients will be randomly assigned to a PR or a control group.

The investigators hypothesize that PR will improve exercise capacity, increase muscle force, reduce dyspnea and improve quality of life and daily life activities in ILD patients.

Enrollment: 60 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diagnosis of interstitial lung disease according to internationally established criteria
• Dyspnea on exertion
• Stable medical therapy
• Stable clinical condition at inclusion, with no infection or exacerbation in the previous 4 weeks

Exclusion criteria

• Co-morbidities that do not allow exercise training (unstable angina, recent myocardial infarction or cerebrovascular accident, active cancer, severe orthopedic disorders).
• Life expectancy below 3 months

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

60 participants in 2 patient groups

1

Active Comparator group

Description:

Pulmonary Rehabilitation

Treatment:

Other: Pulmonary Rehabilitation

2

No Intervention group